Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Letrozole versus letrozole plus lapatinib in hormone-sensitive HER2-negative operable breast cancer
2006-001907-13Phase 2Completed
- Sponsor
- GSK
- Start
- Aug 2006
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in breast cancer comparing Letrozole + lapatinib with Letrozole + placebo (2 arms). Primary endpoint: Clinical objective response rate. Started Aug 2006; status: completed.
02
Drugs
lapatinibletrozole
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2006-001907-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-001907-13.